How big is the Meningococcal Vaccines Market?

The Meningococcal Vaccines Market size is expected to reach USD 2.9 billion in 2024 and grow at a CAGR of 7.60% to reach USD 4.20 billion by 2029. Read More

What is the current Meningococcal Vaccines Market size?

In 2024, the Meningococcal Vaccines Market size is expected to reach USD 2.9 billion. Read More

Who are the key players in Meningococcal Vaccines Market?

Novartis AG, Pfizer Inc., Sanofi, GSK plc and Cyrus Poonawalla Group (Serum Institute of India Ltd.) are the major companies operating in the Meningococcal Vaccines Market. Read More

Which is the fastest growing region in Meningococcal Vaccines Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Meningococcal Vaccines Market?

In 2024, the North America accounts for the largest market share in Meningococcal Vaccines Market. Read More

What years does this Meningococcal Vaccines Market cover, and what was the market size in 2023?

In 2023, the Meningococcal Vaccines Market size was estimated at USD 2.68 billion. The report covers the Meningococcal Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Meningococcal Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Meningococcal Vaccines Companies

This report lists the top Meningococcal Vaccines companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Meningococcal Vaccines industry.